Sofinnova Venture Partners XI, L.P.

13D and 13G Filings

13D/G filings
13D on 1 security
Location
Menlo Park, CA
CIK
0001882303
Form D filings
3 filings
All SEC filings
View on sec.gov
Issuer % of Class Filed
Schedule 13D · 1 security · may seek to influence control
Rapport Therapeutics, Inc. 13D/A
RAPP · 75383L102
4.2% 9/18/2025
Event 9/11/2025

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.